{"entity":{"type":"insider","cik":"0001903716","url":"/insider/0001903716","json_url":"/insider/0001903716.json","name":"Rajavelu Esther","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2024-11-12","last":"2026-05-06","span_basis":"filed_date"},"name_variants":[{"name":"Rajavelu Esther","source":"filing","n_filings":6,"first_seen":"2024-11-12","last_seen":"2026-05-06"}],"transactions":[{"id":5762963,"accession":"0001193125-26-209884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-209884","line_url":"/filing/0001193125-26-209884#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25240.0,"shares_display":"25,240","price_per_share":2.51,"price_display":"2.51","price_state":"stated","total_value":63352.4,"total_display":"63,352.40","total_whole":"63,352","shares_owned_after":986851.0,"shares_owned_after_display":"986,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-06","scope":"insider"},{"id":5958435,"accession":"0001193125-26-043336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-043336","line_url":"/filing/0001193125-26-043336","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87917.0,"shares_display":"87,917","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":207484.12,"total_display":"207,484.12","total_whole":"207,484","shares_owned_after":1012091.0,"shares_owned_after_display":"1,012,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider","n_lines":2},{"id":6016081,"accession":"0001193125-26-038184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-038184","line_url":"/filing/0001193125-26-038184#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18442.0,"shares_display":"18,442","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":40572.4,"total_display":"40,572.40","total_whole":"40,572","shares_owned_after":1100008.0,"shares_owned_after_display":"1,100,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4298413,"accession":"0001193125-25-278370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-278370","line_url":"/filing/0001193125-25-278370#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40270.0,"shares_display":"40,270","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":95439.9,"total_display":"95,439.90","total_whole":"95,440","shares_owned_after":869450.0,"shares_owned_after_display":"869,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider"},{"id":4375881,"accession":"0000950170-25-014859","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-014859","line_url":"/filing/0000950170-25-014859#line-3","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer (CFO & CBO)","role_mark":"O","role_mark_label":"Officer (CFO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20689.0,"shares_display":"20,689","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":16137.42,"total_display":"16,137.42","total_whole":"16,137","shares_owned_after":724720.0,"shares_owned_after_display":"724,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider"},{"id":2952131,"accession":"0000950170-24-125339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-125339","line_url":"/filing/0000950170-24-125339#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer (CFO & CBO)","role_mark":"O","role_mark_label":"Officer (CFO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17245.0,"shares_display":"17,245","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":22418.5,"total_display":"22,418.50","total_whole":"22,419","shares_owned_after":379270.0,"shares_owned_after_display":"379,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2952127,"accession":"0000950170-24-125339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-125339","line_url":"/filing/0000950170-24-125339#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001903716","owner_name":"Rajavelu Esther","owner_display_name":"Rajavelu Esther","owner_url":"/insider/0001903716","role":"Officer (CFO & CBO)","role_mark":"O","role_mark_label":"Officer (CFO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23351.0,"shares_display":"23,351","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":30589.81,"total_display":"30,589.81","total_whole":"30,590","shares_owned_after":396515.0,"shares_owned_after_display":"396,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701108","name":"Spero Therapeutics, Inc.","url":"/issuer/0001701108","role":"Officer","n_filings":6,"first_seen":"2024-11-12","last_seen":"2026-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001903716","retrieved_at":"2026-08-26T19:10:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}